Nine out of ten Swedes think it is very important to keep research in pharmaceutical companies in Sweden. A majority of citizens is willing to pay more to get access to new and modern pharmaceuticals. At the same time, the industry thinks the biggest threat to the industry is the lack of willingness to pay for innovative pharmaceuticals. This is one of many interesting results which appear in a new survey on the pharmaceutical industry.
Pharma Industry has in cooperation with the trade association for the research-based pharmaceutical industry in Sweden LIF and Opticom International Research conducted a survey in which the pharmaceutical industry itself evaluates its conditions. A new element this year is that the survey also has studied the general public’s opinion on the pharmaceutical industry.